Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Reiberger

Showing results (61-70 of 490) with videos related to

Pageof 49
Sort By:
Journal of Hepatology|May 13, 2026
Reply to: "Early Abstinence, Socioeconomic Barriers, and Survival in Decompensated Alcohol-Related Cirrhosis: A Real-World Cohort from China"Benedikt Silvester Hofer, Marta Tonon, Thomas Reiberger
Alimentary Pharmacology & Therapeutics|September 28, 2023
Letter: NSBB for fatty liver disease-Still a long way to go. Authors' replyMathias Jachs, Rafael Paternostro, Thomas Reiberger, et al.
Journal of Hepatology|June 22, 2024
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammationVlad Taru, Gyongyi Szabo, Wajahat Mehal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 29, 2022
Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?Peter Ferenci, Thomas Reiberger, Vanessa Stadlbauer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated CirrhosisLorenzo Lani, Bernhard Scheiner, Matthias Pinter, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 5, 2026
Radio-HVPG: Considerations and Limitations for Risk Prediction in Patients With CirrhosisMartina Scharitzer, Katharina Lampichler, Clemens Watzenböck, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' replyMattias Mandorfer, Bernhard Scheiner, Thomas Reiberger, et al.
World Journal of Gastroenterology|October 30, 2019
Gut-liver axis signaling in portal hypertensionBenedikt Simbrunner, Mattias Mandorfer, Michael Trauner, et al.
Alimentary Pharmacology & Therapeutics|December 10, 2025
Editorial: ICG-R15 by PDD-A Simple Dynamic Tool for Refining Risk Stratification in Compensated Advanced Chronic Liver Disease. Authors' ReplyMattias Mandorfer, Mathias Jachs, Tânia Carvalho, et al.
Pageof 49

Showing results (61-70 of 490) with videos related to

Sort By:
Pageof 49
Journal of Hepatology|May 13, 2026
Reply to: "Early Abstinence, Socioeconomic Barriers, and Survival in Decompensated Alcohol-Related Cirrhosis: A Real-World Cohort from China"Benedikt Silvester Hofer, Marta Tonon, Thomas Reiberger
Alimentary Pharmacology & Therapeutics|September 28, 2023
Letter: NSBB for fatty liver disease-Still a long way to go. Authors' replyMathias Jachs, Rafael Paternostro, Thomas Reiberger, et al.
Journal of Hepatology|June 22, 2024
Inflammasomes in chronic liver disease: Hepatic injury, fibrosis progression and systemic inflammationVlad Taru, Gyongyi Szabo, Wajahat Mehal, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 29, 2022
Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?Peter Ferenci, Thomas Reiberger, Vanessa Stadlbauer, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 30, 2025
Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated CirrhosisLorenzo Lani, Bernhard Scheiner, Matthias Pinter, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 5, 2026
Radio-HVPG: Considerations and Limitations for Risk Prediction in Patients With CirrhosisMartina Scharitzer, Katharina Lampichler, Clemens Watzenböck, et al.
Alimentary Pharmacology & Therapeutics|September 25, 2018
Editorial: surviving your genes-the role of PNPLA3 variation in end-stage liver disease. Authors' replyMattias Mandorfer, Bernhard Scheiner, Thomas Reiberger, et al.
World Journal of Gastroenterology|October 30, 2019
Gut-liver axis signaling in portal hypertensionBenedikt Simbrunner, Mattias Mandorfer, Michael Trauner, et al.
Alimentary Pharmacology & Therapeutics|December 10, 2025
Editorial: ICG-R15 by PDD-A Simple Dynamic Tool for Refining Risk Stratification in Compensated Advanced Chronic Liver Disease. Authors' ReplyMattias Mandorfer, Mathias Jachs, Tânia Carvalho, et al.
Pageof 49